It’s that time of year again! Are you aware, according to the American Cancer Society, it is projected that there will be over 234,000 new cases of lung and bronchus cancers in 2018 alone??? About 8,500 of them are expected to be in NC. Of the men and women with lung cancer, about 17.9% have never smoked.
For those of you not on Facebook and haven’t already seen, Gwen would love to help raise money for research on her specific type of lung cancer (ROS-1). Here is a link to her fundraising page: Gwen Strong – The ROS1ders .
I know it has been forever since I have written. Life has been busy and Gwen has been fairly healthy so there hasn’t been much to report! She ran in the annual LUNGe Forward 5K sponsored by the Lung Cancer Initiative of NC.
Gwen was the first female survivor to finish AND got first place for female in her age group! Justin won in his age group as well.
Here’s a shot of all the GwenStrong winners. We were well represented on “the podium.”
She had an eye appointment recently and things continue to look good there. Last week was “scan week.” I had the opportunity to travel with her to Boston. There are a few tiny nodules that are showing in her right lung. These apparently have been present on the past couple of scans, however they are so small that they were not noticed until an observant technician saw them last week and then the previous scans were pulled up to compare. However, these nodules were NOT present a year ago. Both Dr. Garst here in Raleigh and Dr. Shaw in Boston are not concerned at this time as these nodules could simply be a sign of some kind of normal inflammation that we would all occasionally get and never notice, but they will certainly be keeping a close watch on these spots over the coming months.
Other than that, the rest of her body scans were free and clear. Her brain continues to be clear of all the tumors that were present before, and Gwen is not reporting much in terms of side effects.
The FDA is getting ready to approve the drug that she is getting in Boston, which is cool, but it will likely only be approved for patients with ALK lung cancer
even though the drug is clearly also working for patients with ROS-1 so the FDA should stop being stingy with their approvals. At any rate, Gwen would like to stay on the trial to continue helping ROS-1 research, so she will still have to travel up to Boston but may be able to go less frequently in the not-so-distant future.
It was a lovely day in Boston and we actually got to walk around some. The picture on the left is the view from the hallway outside the drs office and the pic on the right is said hallway. Gwen and I both just really like that hallway. It looks cool.